Published January 1, 2024
| Version v1
Other
Open
Insulin therapy de-intensification with iGlarLixi (IDEAL) ran domised controlled trial: CGM-related outcomes
Authors/Creators
- 1. Institut klinicke a experimentalni mediciny
- 2. EDUMED s.r.o., Náchod, Czechia
- 3. Internal and Diabetology Clinic, Valašské Kloubouky, Czechia
- 4. Private Diabetology Clinic, Krnov, Czechia
- 5. Diaclinic s.r.o., České Budějovice, Czechia
Notes
The project National Institute for Research of Metabolic and Cardiovascular Diseases (Programme EXCELES, Project No. LX22NPO5104); Funded by the European Union; Next Generation EU
Files
EASD_Insulin_therapy.pdf
Files
(3.1 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:6543eed8783ffebed3563bd1e699cbc4
|
3.1 MB | Preview Download |
Additional details
Related works
- Is part of
- 0012-186X (ISSN)
- 1432-0428 (ISSN)